Search results
Results from the WOW.Com Content Network
The European Respiratory Journal is a monthly peer-reviewed medical journal covering respirology. It was established in 1988 and is published by the European Respiratory Society, of which it is the official journal. The editor-in-chief is James D. Chalmers (University of Dundee).
The European Respiratory Review is published quarterly and focuses on state-of-the-art reviews, updates, editorials and correspondence on current topical issues in respiratory medicine, science and surgery. Its chief editor is Renata Riha. ERJ Open Research is an open access research journal, launched in 2015. [4] Its chief editor is Esther ...
English: 2006–present European Journal of Cancer Prevention: Oncology: Lippincott Williams & Wilkins: English: 1991–present European Journal of Clinical Investigation: Medicine: John Wiley & Sons: English: 1970–present European Journal of General Practice: Family medicine: Taylor & Francis: English: 1995–present European Journal of ...
This page was last edited on 14 October 2011, at 07:33 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
European Molecular Biology Organization Press: Unrestricted No updated versions may be posted to preprint servers after initial submission to the journal. Unrestricted [43] European Respiratory Society: Unrestricted Versions of a manuscript that have been altered as a result of the peer review process may not be deposited Unrestricted [44 ...
Pulmonology (/ ˌ p ʌ l m ə ˈ n ɒ l ə dʒ i /, / ˌ p ʊ l m ə ˈ n ɒ l ə dʒ i /, from Latin pulmō, -ōnis "lung" and the Greek suffix -λογία-logía "study of"), pneumology (/ n ʊ ˈ m ɒ l ə dʒ i, n j ʊ-/, built on Greek πνεύμων pneúmōn "lung") or pneumonology [1] (/ n ʊ m ə n ˈ ɒ l ə dʒ i, n j ʊ-/) is a medical specialty that deals with diseases involving ...
Pulmonary rehabilitation, also known as respiratory rehabilitation, is an important part of the management and health maintenance of people with chronic respiratory disease who remain symptomatic or continue to have decreased function despite standard medical treatment. It is a broad therapeutic concept.
In 1992, NO was voted molecule of the year by the scientific journal Science. [33] In 1993, researchers from the Karolinska Institute in Sweden were the first to report increased eNO in asthmatics. [34] The first commercial FeNO testing device was developed in 1998 by the Swedish company Aerocrine AB, which is now a part of the NIOX Group of ...